Goldman Sachs Starts CVS Health (CVS) at Buy
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $95.43 +0.75%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst Scott Fidel initiates coverage on CVS Health (NYSE: CVS) with a Buy rating and a price target of $91.00.
For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.
Shares of CVS Health closed at $78.44 yesterday.
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $118 at JPMorgan
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
- Citi Starts Sibyane Stillwater (SBSW) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
